Eli Lilly Acquires Merida Biosciences to Expand Diabetes Drug Portfolio

The American pharmaceutical giant Eli Lilly has purchased Merida Biosciences in a multi-billion dollar deal aimed at strengthening its immunology and weight-loss medication pipeline.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

der-standardGerman3h ago

Eli Lilly stärkt Immunologiegeschäft mit Milliardenzukauf

Der US-Pharmakonzern übernimmt Merida Biosciences und setzt damit seine Einkaufstour fort. Das Rennen am Markt für Abnehmmedikamente wird enger

Read full article →

Eli Lilly Acquires Merida Biosciences to Expand Diabetes Drug Portfolio

Sources

Eli Lilly stärkt Immunologiegeschäft mit Milliardenzukauf

Related Stories

India’s Economy Surges 7.8% Despite Middle East Tensions

Belgium Opposes Using Frozen Russian Assets for Ukrainian Support

Smackover Lithium and LG Energy Solution Sign Multi-Year Supply Deal

European Inflation Accelerates Across Multiple Nations in August